inforMED
MalfunctionKSS

TERUMO SAMPLING SITE COUPLER

Received Apr 30, 2026 · Event occurred Feb 26, 2026

Report 9681839-2026-00036 · MDR key 25049095

Device

Generic name

Tc*mp1 Sampling Site Coupler

Manufacturer

Terumo Corporation

Catalog number

1TCMP1

Lot number

250127P2

Product problems

  • Adverse Event Without Identified Device or Use Problem

Patient

Not reported

  • No Clinical Signs, Symptoms or Conditions

Narrative

Description of Event or Problem

CUSTOMER REPORTED POSITIVE STERILITY ON GLYCEROLIZATION PROCESS. NO PATIENT (DONOR) WAS CONNECTED AT THE TIME OF THE EVENT; THEREFORE, NO PATIENT INFORMATION IS AVAILABLE. THE COLLECTION SET IS NOT AVAILABLE FOR RETURN BECAUSE IT WAS DISCARDED BY THE CUSTOMER.

Additional Manufacturer Narrative

INVESTIGATION: THE SET IN QUESTION WAS NOT RETURNED FOR INVESTIGATION.INVESTIGATION RESULT OF MANUFACTURING PROCESS THE PRODUCT CONCERNED IS MANUFACTURED ACCORDING TO THE FOLLOWING PROCESS FLOW. ATTACH THE PROTECTOR, THE RUBBER CAP, AND THE CAP TO THE SPIKE. (ASSEMBLING)VISUALLY INSPECT THE ASSEMBLY.PACK THE ASSEMBLY INTO THE INDIVIDUAL PACKAGE, AND SEAL THE PACKAGE WITH THE PACKAGE SEALING MACHINE. PACK 50 SEALED INDIVIDUAL PACKAGE INTO ONE UNIT BOX.WEIGH THE UNIT BOX TO VERIFY THE QUANTITY INSIDE THE BOX. PACK 20 UNIT BOXES INTO ONE SHIPPING CARTON BOX. LOAD THE SHIPPING CARTON BOXED ON THE STERILIZATION PALLET AND CONDUCT ETO STERILIZATION. THE INVESTIGATION WAS CONDUCTED BASED ON THE REPORTED INFORMATION, AND NO EQUIPMENT MALFUNCTIONS OR DEVIATIONS WERE OBSERVED IN THE ASSEMBLING, PACKAGING, OR STERILIZATION PROCESSES. INVESTIGATION OF OCCURRENCES OF SIMILAR ISSUES IT WAS CONFIRMED THAT NO SIMILAR ISSUES HAD BEEN REPORTED FROM OTHER MEDICAL FACILITIES AS OF APRIL 14, 2026. REGARDING THE PRODUCT CONCERNED, THERE HAVE BEEN NO RECALLS ASSOCIATED WITH POSITIVE STERILITY. ROOT CAUSE: BASED ON THE INVESTIGATIONS ABOVE, NO ABNORMALITIES WERE IDENTIFIED IN THE ASSEMBLING, PACKAGING, OR STERILIZATION PROCESSES, AND NO SIMILAR ISSUES HAVE BEEN REPORTED BY OTHER FACILITIES. THEREFORE, WE WERE UNABLE TO IDENTIFY THE SPECIFIC CAUSE OF THE OCCURRENCE OF THIS ISSUE. AS STATED IN THE IFU, THIS PRODUCT SHOULD BE USED IMMEDIATELY AFTER OPENING THE PACKAGE, AND SHOULD NOT BE REUSED, RE-STERILIZED, OR REPROCESSED.